首页> 外文期刊>Acta bio-medica: Atenei Parmensis >Effects of D-Mannose, ElliroseTM and Lactobacillus Plantarum in treatment of urinary tract recurrent infections (rUTIs): A survey of urologists knowledge about its clinical application.
【24h】

Effects of D-Mannose, ElliroseTM and Lactobacillus Plantarum in treatment of urinary tract recurrent infections (rUTIs): A survey of urologists knowledge about its clinical application.

机译:D-甘露糖,ELLIROTERM和乳杆菌Plantarum治疗泌尿道复发性感染的影响(RUTIS):泌尿科医生对其临床应用的综述。

获取原文
获取外文期刊封面目录资料

摘要

Background and aim of the work: Urinary tract infections (UTIs) and recurrent urinary tract infections (rUTIs) are widespread disease and almost half of all women will experience at least one episode of cystitis during their life. Aim of this study was to review the evidence of literature about the therapeutic and preventive effects of a product containing D-Mannose, Ellirose TM and Lactobacollus Plantarum on patients’ symptoms, quality of life and recurrence of UTIs and to investigate the practicing urologists’ knowledge about the clinical application of this product. Materials: We administrated an investigational survey about clinical use of a phytotherapeutic product made of D-Mannose, Ellirose TM and Lactobacollus Plantarum to 12 residents in Urology at the University of Modena and Reggio Emilia and to 32 urologists working in the provinces of Modena, Reggio Emilia and Parma. Results: 61% of physicians have diagnosed rUTIs in 3-6 patients during a month, and 7% of them in more than 6 patients during the same period of time. By these results rUTIs appear as common pathological conditions. 59% prescribed the product at least 1 time a month and 14% prescribed it more than 5 times. 43% administrated the product after out-patient invasive examinations as cistoscopy and urodynamic exam for UTIs prevention. 55% noticed a significant improvement in patient’s QoL (Quality of Life) suffering from rUTIs. Furthermore 48% also reported a significant effect for the improvement of urinary symptoms of patients. No gastric or general side effects have been noticed during the administration period. Finally the cost of integrator has been reported affordable for the great majority of patients. Conclusions: Many studies in Literature have shown that D-Mannose and H. sabdariffa (Ellirose TM ) reduce the risk of development of rUTIs opposing colonization and proliferation of uropathogenic bacteria in urinary tract. Our investigational survey about the administration of a phytotherapeutic product showed that this product is well-known and has a proved positive impact.
机译:背景和目的的作品:尿路感染(UTI)和复发性尿路感染(RUTIS)是普遍的疾病,几乎一半的女性将在其生命中患上至少一次膀胱炎插曲。本研究的目的是审查文学的证据,了解含有D-甘露糖,Ellirose TM和乳杆菌Plantarum对患者的症状,生活质量和utis的复发的疗效和调查泌尿科医生知识的治疗和预防效果关于本产品的临床应用。材料:我们向莫德纳大学和雷吉奥·艾米利亚大学泌尿外科泌尿科和乳杆菌和乳渣的泌尿外科和泌尿科中的临床应用的临床用途进行了调查。艾米利亚和帕尔马。结果:61%的医生在一个月内为3-6名患者诊断rutis,在同一段时间内超过6名患者7%。通过这些结果,Rutis表现为常见的病理条件。 59%规定了产物每月至少1次,14%规定超过5次。 43%在门诊侵入性检查后给予产物作为静态检查和UTIS预防的尿动力学考试。 55%注意到患者的QoL(生活质量)患有Rutis的重大改善。此外,48%还报告了改善患者泌尿症状的显着效果。在给药期间没有发现胃或一般副作用。最后,患有大多数患者的Integrator的成本已经过高。结论:文献中的许多研究表明,D-Mannose和H. Sabdariffa(Ellirose TM)降低了尿道尿道尿脓毒细菌的罗特斯对抗和扩散的风险。我们关于植物治疗产品的施用的调查显示,该产品是众所周知的,并且具有证明的积极影响。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号